[HTML][HTML] An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels

J De Leon, G Schoretsanitis, RL Smith… - …, 2022 - thieme-connect.com
This international guideline proposes improving clozapine package inserts worldwide by
using ancestry-based dosing and titration. Adverse drug reaction (ADR) databases suggest …

Brain structures and neurotansmitters regulating aggression in cats: implications for human aggression

TR Gregg, A Siegel - Progress in neuro-psychopharmacology and …, 2001 - Elsevier
Violence and aggression are major public health problems. 2. The authors have used
techniques of electrical brain stimulation, anatomical-immunohistochemical techniques, and …

Addictive and non‐addictive drugs induce distinct and specific patterns of ERK activation in mouse brain

E Valjent, C Pagès, D Hervé, JA Girault… - European Journal of …, 2004 - Wiley Online Library
A major goal of research on addiction is to identify the molecular mechanisms of long‐
lasting behavioural alterations induced by drugs of abuse. Cocaine and delta‐9 …

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

P Seeman, T Tallerico - Molecular psychiatry, 1998 - nature.com
This review addresses two questions. First, why does clozapine apparently occupy low
levels of dopamine D2 receptors in patients, in contrast to all other antipsychotic drugs which …

N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity

C Sur, PJ Mallorga, M Wittmann… - Proceedings of the …, 2003 - National Acad Sciences
The molecular and neuronal substrates conferring on clozapine its unique and superior
efficacy in the treatment of schizophrenia remain elusive. The interaction of clozapine with …

Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response

MC Mauri, LS Volonteri, A Colasanti, A Fiorentini… - Clinical …, 2007 - Springer
In the past, the information about the dose-clinical effectiveness of typical antipsychotics was
not complete and this led to the risk of extrapyramidal adverse effects. This, together with the …

Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy

RS Obach - Pharmacological reviews, 2013 - ASPET
Metabolism represents the most prevalent mechanism for drug clearance. Many drugs are
converted to metabolites that can retain the intrinsic affinity of the parent drug for the …

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

DM Weiner, HY Meltzer, I Veinbergs, EM Donohue… - …, 2004 - Springer
Rationale Clozapine is a unique antipsychotic, with efficacy against positive symptoms in
treatment-resistant schizophrenic patients, and the ability to improve cognition and treat the …

Atypical antipsychotics part I: pharmacology, pharmacokinetics, and efficacy

JS Markowitz, CS Brown… - Annals of …, 1999 - journals.sagepub.com
OBJECTIVE: To compare the pharmacology, pharmacokinetics, and efficacy of the newer
atypical antipsychotics with those of conventional agents and existing atypical agents. DATA …

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

P Seeman, R Corbett, HHM Van Tol - Neuropsychopharmacology, 1997 - nature.com
This review examines the possible receptor basis of the atypical action of those atypical
antipsychotic drugs that elicit low levels of Parkinsonism. Such an examination requires …